Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Bronchial Asthma | Research

Agreement between self-reported and registered age at asthma diagnosis in Finland

Authors: Elias Nurmi, Iida Vähätalo, Pinja Ilmarinen, Heidi Andersén, Leena E. Tuomisto, Anssi Sovijärvi, Helena Backman, Lauri Lehtimäki, Linnea Hedman, Arnulf Langhammer, Bright I. Nwaru, Päivi Piirilä, Hannu Kankaanranta

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Introduction

In epidemiological studies, the age at asthma onset is often defined by patients’ self-reported age at diagnosis. The reliability of this report might be questioned. Our objective was to evaluate the agreement between self-reported and registered age at asthma diagnosis and assess features contributing to the agreement.

Methods

As part of the FinEsS respiratory survey in 2016, randomly selected population samples of 13,435 from Helsinki and 8000 from Western Finland were studied. Self-reported age at asthma diagnosis was compared to age at asthma diagnosis registered in the Finnish register on special reimbursement for asthma medication. The reimbursement right is based on lung function criteria according to GINA and Finnish guidelines. If the difference was less than 5 years, self-reported diagnosis was considered reliable. Features associated with the difference between self-reported and registered age at asthma diagnosis were evaluated.

Results

Altogether 197 subjects from Helsinki and 144 from Western Finland were included. Of these, 61.9% and 77.8%, respectively, reported age at diagnosis reliably. Median difference between self-reported and registered age at diagnoses was − 2.0 years (IQR − 9.0 to 0) in Helsinki and − 1.0 (IQR − 4.3 to 0) in Western Finland indicating earlier self-reported age at diagnosis. More reliable self-report was associated with non-allergic subjects and subjects who reported having asthma diagnosis more recently.

Conclusions

Agreement between self-reported and registered age at asthma diagnosis was good especially with adult-onset asthma patients. Poor agreement in early-onset asthma could be related to delay in registration due to reimbursement criteria.
Appendix
Available only for authorised users
Literature
16.
go back to reference Asthma. Current Care Guidelines. Working group set by the Finnish Medical Society Duodecim, the Finnish Respiratory Society, the Finnish Peadiatric Society and the Finnish Society of Clinical Physiology. Helsinki: The Finnish Medical Society Duodecim. 2022. Available from https://kaypahoito.fi/. Accessed September 25, 2023. Asthma. Current Care Guidelines. Working group set by the Finnish Medical Society Duodecim, the Finnish Respiratory Society, the Finnish Peadiatric Society and the Finnish Society of Clinical Physiology. Helsinki: The Finnish Medical Society Duodecim. 2022. Available from https://​kaypahoito.​fi/​. Accessed September 25, 2023.
20.
37.
go back to reference Aro S, Koskinen R, Keskimäki I. [Reliability of hospital discharge data concerning diagnosis, treatments and accidents]. Duodecim Laaketieteellinen Aikakauskirja. 1990;106(21):1443–50.PubMed Aro S, Koskinen R, Keskimäki I. [Reliability of hospital discharge data concerning diagnosis, treatments and accidents]. Duodecim Laaketieteellinen Aikakauskirja. 1990;106(21):1443–50.PubMed
Metadata
Title
Agreement between self-reported and registered age at asthma diagnosis in Finland
Authors
Elias Nurmi
Iida Vähätalo
Pinja Ilmarinen
Heidi Andersén
Leena E. Tuomisto
Anssi Sovijärvi
Helena Backman
Lauri Lehtimäki
Linnea Hedman
Arnulf Langhammer
Bright I. Nwaru
Päivi Piirilä
Hannu Kankaanranta
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-02949-3

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine